Company / Free Cash Flow
Disc Medicine, Inc. Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$181.3M
FY2025
5-year range
-$181.3M / -$27.6M
FY2021-FY2025
Trend
-92.0%
vs FY2024
Sector context
#145 of 194
Health Care
What the data says
Disc Medicine, Inc.'s free cash flow of -$181M is lower than 75% of companies in the Health Care sector (FY2025). Free Cash Flow has declined for 4 consecutive years, from -$28M in FY2021 to -$181M in FY2025.
Based on SEC 10-K filings.
-$181M in FY2025.
Declined from -$74M to -$181M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 194This company -$181.3M Sector average $470.8M
▼
-138.5% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s free cash flow has declined for 4 consecutive years.
- In FY2025, free cash flow decreased 92.0% year-over-year.
- Ranks #145 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$181.3M | -92.0% |
| FY2024 | -$94.4M | -28.4% |
| FY2023 | -$73.6M | -73.5% |
| FY2022 | -$42.4M | -53.6% |
| FY2021 | -$27.6M | +15.7% |
| FY2020 | -$32.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026